ATTAIN-1 (NCT05869903), a 72-week, randomized, double-blind, placebo-controlled trial comparing the efficacy and safety of orforglipron (6 mg, 12 mg, and 36 mg) as monotherapy vs
The first involved GLP-1 (7-37) synthesized by Mojsov, which was overseen by David Nathan, a physician and director of the Diabetes Clinic at MGH
That's a huge number of people on personalized dosing
My feet got smaller about six months after I started a GLP-1
Chances are, youve heard about GLP-1 receptor agonist medications and the potential benefits they might bring to bear on your health concerns and goals
The methionine, inositol, and choline are lipotropic agents compounds that support fat metabolism in the liver